(NKTR) Nektar Therapeutics - Performance 81.4% in 12m
NKTR performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-88.52%
#171 in Peer-Group
Rel. Strength
92.18%
#584 in Stock-Universe
Total Return 12m
81.43%
#15 in Peer-Group
Total Return 5y
-91.34%
#153 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 29.12 USD |
| 52 Week Low | 7.36 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 99.57 |
| Buy/Sell Signal +-5 | 0.00 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: NKTR (81.4%) vs XLV (-7.1%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-3.67% | 143% | 342% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
9.25% | -11.8% | 416% | 63.7 | 36 | 1.2 | 58.2% | 18.9% |
| NVS NYSE Novartis |
4.23% | 13.9% | 74.9% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
1.41% | 2.61% | 46.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
| GSK NYSE GlaxoSmithKline |
-2.94% | -0.85% | 47.7% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-7.61% | -1.2% | 117% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| AZN NASDAQ AstraZeneca |
-1.8% | -10.9% | 47.7% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
1.16% | -10.2% | 43.5% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: NKTR vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for NKTR
| Total Return (including Dividends) | NKTR | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 187.82% | 1.80% | 3.01% |
| 3 Months | 131.86% | -7.39% | 5.82% |
| 12 Months | 81.43% | -7.13% | 12.82% |
| 5 Years | -91.34% | 47.29% | 114.16% |
| Trend Score (consistency of price movement) | NKTR | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -28.3% | 54% | 78.3% |
| 3 Months | 7.2% | -57.4% | 87.1% |
| 12 Months | -84% | -69.2% | 43.5% |
| 5 Years | -85.8% | 88.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #1 | 182.73% | 179.42% |
| 3 Month | #1 | 150.35% | 119.11% |
| 12 Month | #14 | 95.36% | 60.81% |
| 5 Years | #153 | -94.12% | -95.96% |
FAQs
Does Nektar Therapeutics (NKTR) outperform the market?
Yes,
over the last 12 months NKTR made 81.43%, while its related Sector, the Health Care Sector SPDR (XLV) made -7.13%.
Over the last 3 months NKTR made 131.86%, while XLV made -7.39%.
Performance Comparison NKTR vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
NKTR vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 236.3% | 184.8% | 102.5% | 69% |
| US NASDAQ 100 | QQQ | 235.8% | 183.9% | 101.6% | 68% |
| German DAX 40 | DAX | 237.4% | 190.9% | 86.9% | 53% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 234.7% | 183.6% | 102% | 62% |
| Hongkong Hang Seng | HSI | 233.8% | 179.6% | 83.5% | 46% |
| India NIFTY 50 | INDA | 236% | 187% | 100.8% | 81% |
| Brasil Bovespa | EWZ | 240% | 187.5% | 80.5% | 75% |
NKTR vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 236.3% | 184.2% | 97.3% | 58% |
| Consumer Discretionary | XLY | 236.8% | 189.4% | 112.4% | 62% |
| Consumer Staples | XLP | 237.8% | 189.7% | 102.2% | 75% |
| Energy | XLE | 241.5% | 184.8% | 102.5% | 86% |
| Financial | XLF | 235.5% | 186.5% | 98.7% | 55% |
| Health Care | XLV | 237.2% | 186% | 107.3% | 89% |
| Industrial | XLI | 236.8% | 187.2% | 96.3% | 62% |
| Materials | XLB | 237.9% | 187.8% | 101.4% | 82% |
| Real Estate | XLRE | 238.8% | 187.1% | 101.7% | 69% |
| Technology | XLK | 234.8% | 180.3% | 100.1% | 71% |
| Utilities | XLU | 237.6% | 188.6% | 97.1% | 61% |
| Aerospace & Defense | XAR | 235.6% | 183.1% | 85.7% | 37% |
| Biotech | XBI | 237.5% | 182.8% | 114.2% | 92% |
| Homebuilder | XHB | 234.2% | 187.6% | 112.5% | 85% |
| Retail | XRT | 237.7% | 187.5% | 110.1% | 79% |
NKTR vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 249.1% | 179% | 104% | 89% |
| Natural Gas | UNG | 250.5% | 195% | 101% | 98% |
| Gold | GLD | 239.2% | 187% | 77.7% | 38% |
| Silver | SLV | 239% | 178.6% | 82.5% | 56% |
| Copper | CPER | 236.5% | 183.7% | 84.9% | 68% |
NKTR vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 237.2% | 185.4% | 102.7% | 85% |
| iShares High Yield Corp. Bond | HYG | 237.5% | 186.4% | 99.9% | 72% |